Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Paclitaxel Market by Manufacturers, States, Type and Application, Forecast to 2022

  • GLO1453778
  • 123 Pages
  • August 2017
  • Healthcare
Download Sample    Get Discount   
 
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Scope of the Report:

This report focuses on the Paclitaxel in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius-kabi

Southpharma

Haiyao

Huiang biopharma

Yunnan Hande

Hainan Yew Pharm

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Market Segment by Type, covers

Natural Paclitaxel

Semi-synthetic Paclitaxel

Market Segment by Applications, can be divided into

Ovarian Cancer

Cervical Cancer

Breast Cancer

Other

There are 17 Chapters to deeply display the United States Paclitaxel market.

Chapter 1, to describe Paclitaxel Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Paclitaxel, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Paclitaxel, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Paclitaxel market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Paclitaxel Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents

1 Market Overview

1.1 Paclitaxel Introduction

1.2 Market Analysis by Type

1.2.1 Natural Paclitaxel

1.2.2 Semi-synthetic Paclitaxel

1.3 Market Analysis by Applications

1.3.1 Ovarian Cancer

1.3.2 Cervical Cancer

1.3.3 Breast Cancer

1.3.4 Other

1.4 Market Analysis by States

1.4.1 California Status and Prospect (2012-2022)

1.4.2 Texas Status and Prospect (2012-2022)

1.4.3 New York Status and Prospect (2012-2022)

1.4.4 Florida Status and Prospect (2012-2022)

1.4.5 Illinois Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Phyton

2.1.1 Profile

2.1.2 Paclitaxel Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Phyton News

2.2 ScinoPharm

2.2.1 Profile

2.2.2 Paclitaxel Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 ScinoPharm News

2.3 Novasep

2.3.1 Profile

2.3.2 Paclitaxel Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Novasep News

2.4 Samyang

2.4.1 Profile

2.4.2 Paclitaxel Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Samyang News

2.5 Polymed

2.5.1 Profile

2.5.2 Paclitaxel Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Polymed News

2.6 TAPI (Teva)

2.6.1 Profile

2.6.2 Paclitaxel Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 TAPI (Teva) News

2.7 Fresenius-kabi

2.7.1 Profile

2.7.2 Paclitaxel Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Fresenius-kabi News

2.8 Southpharma

2.8.1 Profile

2.8.2 Paclitaxel Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Southpharma News

2.9 Haiyao

2.9.1 Profile

2.9.2 Paclitaxel Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Haiyao Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Haiyao News

2.10 Huiang biopharma

2.10.1 Profile

2.10.2 Paclitaxel Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.4 Business Overview

2.10.5 Huiang biopharma News

2.11 Yunnan Hande

2.11.1 Profile

2.11.2 Paclitaxel Type and Applications

2.11.2.1 Type 1

2.11.2.2 Type 2

2.11.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11.4 Business Overview

2.11.5 Yunnan Hande News

2.12 Hainan Yew Pharm

2.12.1 Profile

2.12.2 Paclitaxel Type and Applications

2.12.2.1 Type 1

2.12.2.2 Type 2

2.12.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12.4 Business Overview

2.12.5 Hainan Yew Pharm News

3 United States Paclitaxel Market Competition, by Manufacturer

3.1 United States Paclitaxel Sales and Market Share by Manufacturer (2016-2017)

3.2 United States Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)

3.3 United States Paclitaxel Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Paclitaxel Manufacturer Market Share

3.4.2 Top 5 Paclitaxel Manufacturer Market Share

3.5 Market Competition Trend

4 United States Paclitaxel Market Analysis by States

4.1 United States Paclitaxel Sales Market Share by States

4.2 United States Paclitaxel Sales by States (2012-2017)

4.3 United States Paclitaxel Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Paclitaxel by Type

5.1 United States Paclitaxel Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 United States Paclitaxel Sales and Market Share by Type (2012-2017)

5.1.2 United States Paclitaxel Revenue and Market Share by Type (2012-2017)

5.2 Natural Paclitaxel Sales Growth and Price

5.2.1 United States Natural Paclitaxel Sales Growth (2012-2017)

5.2.2 United States Natural Paclitaxel Price (2012-2017)

5.3 Semi-synthetic Paclitaxel Sales Growth and Price

5.3.1 United States Semi-synthetic Paclitaxel Sales Growth (2012-2017)

5.3.2 United States Semi-synthetic Paclitaxel Price (2012-2017)

6 United States Market Segmentation Paclitaxel by Application

6.1 United States Paclitaxel Sales Market Share by Application (2012-2017)

6.2 Ovarian Cancer Sales Growth (2012-2017)

6.3 Cervical Cancer Sales Growth (2012-2017)

6.4 Breast Cancer Sales Growth (2012-2017)

6.5 Other Sales Growth (2012-2017)

7 California Paclitaxel Sales, Revenue, by Type, Application and Manufacturers

7.1 California Paclitaxel Revenue, Sales and Growth Rate (2012-2017)

7.2 California Paclitaxel Sales and Market Share by Type

7.3 California Paclitaxel Sales by Application (2012-2017)

8 New York Paclitaxel Sales, Revenue, by Type, Application and Manufacturers

8.1 New York Paclitaxel Revenue, Sales and Growth Rate (2012-2017)

8.2 New York Paclitaxel Sales and Market Share by Type

8.3 New York Paclitaxel Sales by Application (2012-2017)

9 Texas Paclitaxel Sales, Revenue, by Type, Application and Manufacturers

9.1 Texas Paclitaxel Revenue, Sales and Growth Rate (2012-2017)

9.2 Texas Paclitaxel Sales and Market Share by Type

9.3 Texas Paclitaxel Sales by Application (2012-2017)

10 Florida Paclitaxel Sales, Revenue, by Type, Application and Manufacturers

10.1 Florida Paclitaxel Revenue, Sales and Growth Rate (2012-2017)

10.2 Florida Paclitaxel Sales and Market Share by Type

10.3 Florida Paclitaxel Sales by Application (2012-2017)

11 Illinois Paclitaxel Sales, Revenue, by Type, Application and Manufacturers

11.1 Illinois Paclitaxel Revenue, Sales and Growth Rate (2012-2017)

11.2 Illinois Paclitaxel Sales and Market Share by Type

11.3 Illinois Paclitaxel Sales by Application (2012-2017)

12 Paclitaxel Market Forecast (2017-2022)

12.1 United States Paclitaxel Sales, Revenue and Growth Rate (2017-2022)

12.2 Paclitaxel Market Forecast by States (2017-2022)

12.3 Paclitaxel Market Forecast by Type (2017-2022)

12.4 Paclitaxel Market Forecast by Application (2017-2022)

13 Paclitaxel Manufacturing Cost Analysis

13.1 Paclitaxel Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Price Trend of Key Raw Materials

13.1.3 Key Suppliers of Raw Materials

13.1.4 Market Concentration Rate of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.2.1 Raw Materials

13.2.2 Labor Cost

13.2.3 Manufacturing Expenses

13.3 Manufacturing Process Analysis of Paclitaxel

14 Industrial Chain, Sourcing Strategy and Downstream Buyers

14.1 Paclitaxel Industrial Chain Analysis

14.2 Upstream Raw Materials Sourcing

14.3 Raw Materials Sources of Paclitaxel Major Manufacturers in 2016

14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers

15.1 Sales Channel

15.1.1 Direct Marketing

15.1.2 Indirect Marketing

15.1.3 Marketing Channel Future Trend

15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology

17.2 Analyst Introduction

17.3 Data Source

List of Tables and Figures

Figure Paclitaxel Picture

Table Product Specifications of Paclitaxel

Figure United States Sales Market Share of Paclitaxel by Types in 2016

Table Types of Paclitaxel

Figure Natural Paclitaxel Picture

Table Major Manufacturers of Natural Paclitaxel

Figure Semi-synthetic Paclitaxel Picture

Table Major Manufacturers of Semi-synthetic Paclitaxel

Table United States Paclitaxel Sales Market Share by Applications in 2016

Table Applications of Paclitaxel

Figure Ovarian Cancer Picture

Figure Cervical Cancer Picture

Figure Breast Cancer Picture

Figure Other Picture

Figure California Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)

Figure Texas Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)

Figure New York Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)

Figure Florida Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)

Figure Illinois Paclitaxel Revenue (Million USD) and Growth Rate (2012-2022)

Table Phyton Basic Information, Manufacturing Base and Competitors

Table Phyton Paclitaxel Type and Applications

Table Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ScinoPharm Basic Information, Manufacturing Base and Competitors

Table ScinoPharm Paclitaxel Type and Applications

Table ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novasep Basic Information, Manufacturing Base and Competitors

Table Novasep Paclitaxel Type and Applications

Table Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Samyang Basic Information, Manufacturing Base and Competitors

Table Samyang Paclitaxel Type and Applications

Table Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Polymed Basic Information, Manufacturing Base and Competitors

Table Polymed Paclitaxel Type and Applications

Table Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table TAPI (Teva) Basic Information, Manufacturing Base and Competitors

Table TAPI (Teva) Paclitaxel Type and Applications

Table TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Fresenius-kabi Basic Information, Manufacturing Base and Competitors

Table Fresenius-kabi Paclitaxel Type and Applications

Table Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Southpharma Basic Information, Manufacturing Base and Competitors

Table Southpharma Paclitaxel Type and Applications

Table Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Haiyao Basic Information, Manufacturing Base and Competitors

Table Haiyao Paclitaxel Type and Applications

Table Haiyao Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Huiang biopharma Basic Information, Manufacturing Base and Competitors

Table Huiang biopharma Paclitaxel Type and Applications

Table Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Yunnan Hande Basic Information, Manufacturing Base and Competitors

Table Yunnan Hande Paclitaxel Type and Applications

Table Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors

Table Hainan Yew Pharm Paclitaxel Type and Applications

Table Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table United States Paclitaxel Sales by Manufacturer (2016-2017)

Figure United States Paclitaxel Sales Market Share by Manufacturer in 2016

Figure United States Paclitaxel Sales Market Share by Manufacturer in 2017

Table United States Paclitaxel Revenue by Manufacturer (2016-2017)

Figure United States Paclitaxel Revenue Market Share by Manufacturer in 2015

Figure United States Paclitaxel Revenue Market Share by Manufacturer in 2016

Table United States Paclitaxel Price by Manufacturers (2016-2017)

Figure Top 3 Paclitaxel Manufacturer Market Share in 2016

Figure Top 3 Paclitaxel Manufacturer Market Share in 2017

Figure Top 5 Paclitaxel Manufacturer Market Share in 2016

Figure Top 5 Paclitaxel Manufacturer Market Share in 2017

Figure United States Paclitaxel Sales and Growth (2012-2017)

Table United States Paclitaxel Sales by States (2012-2017)

Table United States Paclitaxel Sales Market Share by States (2012-2017)

Figure United States 2012 Paclitaxel Sales Market Share by States

Figure United States 2016 Paclitaxel Sales Market Share by States

Figure United States Paclitaxel Revenue and Growth (2012-2017)

Table United States Paclitaxel Revenue by States (2012-2017)

Table United States Paclitaxel Revenue Market Share by States (2012-2017)

Table United States 2012 Paclitaxel Revenue Market Share by States

Table United States 2016 Paclitaxel Revenue Market Share by States

Table United States Paclitaxel Sales by Type (2012-2017)

Table United States Paclitaxel Sales Share by Type (2012-2017)

Table United States Paclitaxel Revenue by Type (2012-2017)

Table United States Paclitaxel Revenue Share by Type (2012-2017)

Figure United States Natural Paclitaxel Sales Growth (2012-2017)

Figure United States Natural Paclitaxel Price (2012-2017)

Figure United States Semi-synthetic Paclitaxel Sales Growth (2012-2017)

Figure United States Semi-synthetic Paclitaxel Price (2012-2017)

Table United States Paclitaxel Sales by Application (2012-2017)

Table United States Paclitaxel Sales Share by Application (2012-2017)

Figure United States Ovarian Cancer Sales Growth (2012-2017)

Figure United States Cervical Cancer Sales Growth (2012-2017)

Figure United States Breast Cancer Sales Growth (2012-2017)

Figure United States Other Sales Growth (2012-2017)

Figure California Paclitaxel Revenue and Growth (2012-2017)

Figure California Paclitaxel Sales and Growth (2012-2017)

Table California Paclitaxel Sales by Type (2012-2017)

Table California Paclitaxel Sales Market Share by Type (2012-2017)

Table California Paclitaxel Sales by Application (2012-2017)

Table California Paclitaxel Sales Market Share by Application (2012-2017)

Figure New York Paclitaxel Revenue and Growth (2012-2017)

Figure New York Paclitaxel Sales and Growth (2012-2017)

Table New York Paclitaxel Sales by Type (2012-2017)

Table New York Paclitaxel Sales Market Share by Type (2012-2017)

Table New York Paclitaxel Sales by Application (2012-2017)

Table New York Paclitaxel Sales Market Share by Application (2012-2017)

Figure Texas Paclitaxel Revenue and Growth (2012-2017)

Figure Texas Paclitaxel Sales and Growth (2012-2017)

Table Texas Paclitaxel Sales by Type (2012-2017)

Table Texas Paclitaxel Sales Market Share by Type (2012-2017)

Table Texas Paclitaxel Sales by Application (2012-2017)

Table Texas Paclitaxel Sales Market Share by Application (2012-2017)

Figure Florida Paclitaxel Revenue and Growth (2012-2017)

Figure Florida Paclitaxel Sales and Growth (2012-2017)

Table Florida Paclitaxel Sales by Type (2012-2017)

Table Florida Paclitaxel Sales Market Share by Type (2012-2017)

Table Florida Paclitaxel Sales by Application (2012-2017)

Table Florida Paclitaxel Sales Market Share by Application (2012-2017)

Figure Illinois Paclitaxel Revenue and Growth (2012-2017)

Figure Illinois Paclitaxel Sales and Growth (2012-2017)

Table Illinois Paclitaxel Sales by Type (2012-2017)

Table Illinois Paclitaxel Sales Market Share by Type (2012-2017)

Table Illinois Paclitaxel Sales by Application (2012-2017)

Table Illinois Paclitaxel Sales Market Share by Application (2012-2017)

Figure United States Paclitaxel Sales, Revenue and Growth Rate (2017-2022)

Table United States Paclitaxel Sales Forecast by States (2017-2022)

Table United States Paclitaxel Market Share Forecast by States (2017-2022)

Table United States Paclitaxel Sales Forecast by Type (2017-2022)

Table United States Paclitaxel Market Share Forecast by Type (2017-2022)

Table United States Paclitaxel Sales Forecast by Application (2017-2022)

Table United States Paclitaxel Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Paclitaxel

Figure Manufacturing Process Analysis of Paclitaxel

Figure Paclitaxel Industrial Chain Analysis

Table Raw Materials Sources of Paclitaxel Major Manufacturers in 2016

Table Major Buyers of Paclitaxel

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370